ASCRS issues alert about preservative-free epinephrine shortage

There is an impending shortage of preservative-free epinephrine for ophthalmologists due to a formulation alteration from a common provider, according to an alert issued by the American Society of Cataract and Refractive Surgery.
The new formulation, from PAR Pharmaceutical, contains 0.457 mg of sodium metabisulfite and 2.25 mg of tartaric acid per mL and is not for intraocular use.
“Currently, there is no published data or experience with intracameral administration of solutions containing tartaric acid. ASCRS has become aware of several reports of [toxic anterior segment syndrome] that

Full Story →